Knowledge graph
Founder mafia, market maps, research and news connected to this company by Dealroom
Funding history
1 recorded event
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
| LATE VC✓Equity / VC |
Dec 2014 |
$13M |
$52M |
Undisclosed |
— |
Similar companies
Closest operating peers by Dealroom taxonomy
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
BCBLOCKStrain Technology Corp.Developer of the first integrated blockchain platform that registers and tracks intellectual property for the cannabis industry |
Vancouver, Canada |
Operational |
— |
— |
— |
SOSocatiSocati is the leading processor of THC-free full-spectrum hemp |
Woodburn, United States |
Operational |
4,860 |
$38.5M |
$1.1B |
ABArcis BiotechnologyFast & convenient nucleic acid sample preservation and preparation. Prepare RNA & DNA for PCR/NGS in less than 3 minutes |
Daresbury, United Kingdom |
Operational |
4,860 |
$2.6B |
$740M |
BIBioelectronicaA research-stage biotechnology company building next-generation digital tools for drug discovery, diagnostics, and cell sorting |
Reno, United States |
Operational |
930 |
$2.6B |
$740M |
ABARCA biopharmaGenetically-targeted therapies for cardiovascular diseases |
Westminster, United States |
Acquired |
4,860 |
$1.1B |
$184.2M |
SOSoftGeneticsResearchers and clinicians with software analysis tools for genetic analysis |
State College, United States |
Acquired |
18,420 |
$1.1B |
$184.2M |
PLPlumCareAn Alameda, CA-based DNA advisory service for families |
Alameda, United States |
Operational |
72,100 |
$184.2M |
$2.6B |
PEPeriphaGenA biopharmaceutical company focused on the development of herpes simplex virus type I (HSV-1) as a gene therapy vector |
Pittsburgh, United States |
Operational |
930 |
$184.2M |
$2.6B |
Investments and acquisitions
Capital deployed
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
3 investors on the cap table
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors3 additional known investors
IHIHCV
KCKemper Corporation
ZPZiegler Meditech Equity Partners
Founders
73Hidden — book a demo/100
quality score
Key operators
74Hidden — book a demo
quality score
Potential founders
3Hidden — book a demo
likely future founders
Startup mafia
6Hidden — book a demo
alumni-founded startups
Talent movements
32Hidden — book a demo in · 22Hidden — book a demo out
past 12 months
Source: Dealroom Talent Intelligence.
Market sentiment
Posts on X, past 7 days
An AI-synthesised read of the highest-engagement posts about GI View on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…